News
Publications
Multimedia
Conferences
Webcasts
Resources
Subscribe

Spotlight -

Drug Development|

Quality Systems

GK Raju

GK Raju, PhD is Light Pharma CEO, and Research Affiliate, Massachusetts Institute of Technology.

Articles by GK Raju

Risk Management and Assessment for Business Investment Concept. Modern graphic interface showing symbols of strategy in risky plan analysis to control unpredictable loss and build financial safety.| Image credit: Summit Art Creations - stock.adobe.com

ICH Q9: Attaining a Quality-Business Synergy through Quality Risk Management, ROI Analysis, and Highly Capable Facilities

ByRick L. Friedman,David Lebo,Lawrence Liberti,GK Raju

January 15th 2024

This paper explores the relationship between investing in pharmaceutical manufacturing risk reduction and meeting business objectives.

Latest Updated Articles

ICH Q9: Attaining a Quality-Business Synergy through Quality Risk Management, ROI Analysis, and Highly Capable Facilities
Published: January 15th 2024 | Updated:

Trending on Pharmaceutical Technology

Why Investment Strategies Matter for Advancing Pharmaceutical Technologies

AAPS PharmSci 360 2025: Trends in Bioanalysis

© 2025 MJH Life Sciences^®

All rights reserved.